Arthritis Clinical Trials in North Carolina

53 recruiting studies across 2 cities

Browse by City

All Trials in North Carolina

Phase

Trial	Phase	Sponsor	Dist.
Prospective, Multi-Center, Observational, Whole Blood Specimen Collection Study in Participants with Rheumatoid Arthritis with Inadequate Response or Intolerance to a DMARD Starting a New BDMARD or TsDMARD Treatment +/- CsDMARD	—	Aqtual, Inc.	<1 mi
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.	Phase 2	Artiva Biotherapeutics, Inc.	<1 mi
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry	—	Duke University	<1 mi
A Study to Evaluate the Efficacy and Safety of JNJ-77242113 (Icotrokinra) in Biologic-naïve Participants With Active Psoriatic Arthritis	Phase 3	Janssen Research & Development, LLC	<1 mi
Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis	Phase 3	Sun Pharmaceutical Industries Limited	<1 mi
Nipocalimab in Moderate to Severe Sjogren's Disease	Phase 3	Janssen Research & Development, LLC	<1 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines	Phase 3	Takeda	<1 mi
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.	Phase 3	AbbVie	<1 mi
A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis	Phase 2	AbbVie	<1 mi
A Long-term Extension Study of Ustekinumab in Pediatric Participants	Phase 3	Janssen Research & Development, LLC	<1 mi
Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)	—	Zimmer Biomet	<1 mi
Clinical Outcomes Study of the Nexel Total Elbow	N/A	Zimmer Biomet	<1 mi
A Study of Dotinurad Versus Allopurinol in Participants With Gout	Phase 3	Crystalys Therapeutics	<1 mi
A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis	Phase 2	Janssen Research & Development, LLC	<1 mi
Z1 Hip System: Post-Market Clinical Follow Up Study	—	Zimmer Biomet	<1 mi
Primary Subtalar Arthrodesis for Calcaneal Fractures	N/A	Wake Forest University Health Sciences	<1 mi
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).	Phase 1	Novartis Pharmaceuticals	<1 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response	Phase 3	MoonLake Immunotherapeutics AG	<1 mi
Evaluation of Efficacy and Safety of AR882 and XOI Co-administration in Uricase Treatment Failed Patients	Phase 2	Arthrosi Therapeutics	<1 mi
A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis	Phase 3	Janssen Research & Development, LLC	<1 mi
SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization	N/A	CrannMed	<1 mi
Embo Registry; National Registry for Artery Embolization	—	Vascular Solutions of North Carolina	8 mi
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight	Phase 3	Eli Lilly and Company	10 mi
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications	—	AbbVie	11 mi
Post Approval Study2: Hintermann Series H3 Total Ankle Replacement System	N/A	DT MedTech, LLC	11 mi
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))	N/A	DePuy Orthopaedics	20 mi
A Long-term Extension Study of Dazodalibep in Participants With Sjögren's Syndrome (SS)	Phase 3	Amgen	21 mi
Improving Hypertension Control in Rheumatoid Arthritis	N/A	Duke University	21 mi
A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)	Phase 1	UCB Biopharma SRL	21 mi
Targeted Remotely-delivered Anti-inflammatory Interventions With Exercise for Rheumatoid Arthritis	N/A	Duke University	21 mi
Exactech Shoulder Post Market Clinical Follow-up Study	—	Exactech	21 mi
G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study	N/A	Zimmer Biomet	21 mi
A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic	—	Sonoma Biotherapeutics, Inc.	21 mi
Evaluating Hemidiaphragmatic Paralysis With Prolonged Neural Blockade From an Interscalene Brachial Plexus Block	—	Duke University	21 mi
SMR Stemless Reverse Vs SMR Reverse Shoulder System	N/A	Limacorporate S.p.a	21 mi
Exactech Vantage Total Ankle System Post Market Clinical Follow-Up - US Only	—	Exactech	21 mi
Maternal Autoimmune Disease Research Alliance (MADRA) Registry	—	Duke University	21 mi
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases	Phase 1	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	21 mi
Gait Rehabilitation to Treat FastOA	N/A	University of North Carolina, Chapel Hill	25 mi
Addressing Neuromuscular Deficits for Improved Outcomes in Ankle Rehabilitation	N/A	Phillip Gribble	25 mi
The Osteoarthritis Prevention Study	N/A	Wake Forest University	25 mi
Preventing Injured Knees From osteoArthritis: Severity Outcomes	Phase 2	Brigham and Women's Hospital	25 mi
Knee Biofeedback Rehabilitation Through Game Therapy	N/A	Barron Associates, Inc.	25 mi
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab	Phase 3	AbbVie	25 mi
Vibration and Post-traumatic Osteoarthritis Risk Following ACL Injury	N/A	University of North Carolina, Chapel Hill	25 mi
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1)	Phase 1	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	25 mi
A Study of AZD0120 in Autoimmune Diseases	Phase 1	AstraZeneca	25 mi
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis Naive to Biologic Disease-Modifying Antirheumatic Drug	Phase 3	MoonLake Immunotherapeutics AG	37 mi
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome	Phase 3	Bristol-Myers Squibb	37 mi
An Adaptive Phase 2a/2b Study of LY3871801 in Adult Participants With Rheumatoid Arthritis	Phase 2	Eli Lilly and Company	37 mi
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)	Phase 4	Eli Lilly and Company	37 mi
A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee	Phase 3	Eli Lilly and Company	39 mi
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines	Phase 3	Takeda	45 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.